TEBCARI Trademark
Trademark Overview
On Thursday, March 7, 2024, a trademark application was filed for TEBCARI with the United States Patent and Trademark Office. The USPTO has given the TEBCARI trademark a serial number of 98438634. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, June 25, 2025. This trademark is owned by GLAXO GROUP LIMITED. The TEBCARI trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders
General Information
Serial Number | 98438634 |
Word Mark | TEBCARI |
Filing Date | Thursday, March 7, 2024 |
Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
Status Date | Wednesday, June 25, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, July 15, 2025 |
Trademark Statements
Goods and Services | Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, March 7, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | GLAXO GROUP LIMITED |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Stevenage SG12NY GB |
Trademark Events
Event Date | Event Description |
Thursday, March 7, 2024 | NEW APPLICATION ENTERED |
Thursday, March 7, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, September 20, 2024 | SUSPENSION LETTER WRITTEN |
Friday, September 20, 2024 | LETTER OF SUSPENSION E-MAILED |
Wednesday, September 18, 2024 | ASSIGNED TO EXAMINER |
Tuesday, May 13, 2025 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
Friday, September 20, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Saturday, April 19, 2025 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
Tuesday, May 13, 2025 | SUSPENSION INQUIRY WRITTEN |
Tuesday, May 13, 2025 | INQUIRY TO SUSPENSION E-MAILED |
Friday, June 6, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, June 6, 2025 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Wednesday, July 9, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Thursday, June 12, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, June 6, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |